Relatively few virulence genes have been identified in pathogenic mycoplasmas, so we used signature-tagged mutagenesis to identify mutants of the avian pathogen Mycoplasma gallisepticum with a reduced capacity to persist in vivo and compared the levels of virulence of selected mutants in experimentally infected chickens. Four mutants had insertions in one of the two incomplete oppABCDF operons, and a further three had insertions in distinct hypothetical genes, two containing peptidase motifs and one containing a member of a gene family. The three hypothetical gene mutants and the two with insertions in oppD 1 were used to infect chickens, and all five were shown to have a reduced capacity to induce respiratory tract lesions. One oppD 1 mutant and the MGA_1102 and MGA_1079 mutants had a greatly reduced capacity to persist in the respiratory tract and to induce systemic antibody responses against M. gallisepticum. The other oppD 1 mutant and the MGA_0588 mutant had less capacity than the wild type to persist in the respiratory tract but did elicit systemic antibody responses. Although M. gallisepticum carries two incomplete opp operons, one of which has been acquired by horizontal gene transfer, our results suggest that one of the copies of oppD may be required for full expression of virulence. We have also shown that three hypothetical genes, two of which encode putative peptidases, may be required for full expression of virulence in M. gallisepticum. None of these genes has previously been shown to influence virulence in pathogenic mycoplasmas.
KEYWORDS Mycoplasma gallisepticum, oppD, virulence
Mycoplasma gallisepticum is the most important mycoplasmal pathogen in poultry (1, 2) and a particularly useful model of mycoplasmal pathogenesis, in part as a typical representative of the Pneumoniae phylogenic group, which includes the important human pathogen M. pneumoniae. There have been relatively few studies attempting to identify virulence genes in mycoplasmas, in part because of the limited availability of tools for such studies. Signature-tagged mutagenesis (STM) is a useful technique for identifying genes likely to be involved in virulence, as it enables the rapid comparison of populations of mutants used to inoculate animals with those recovered from these animals during the course of infection, allowing identification of mutants with a reduced capacity to persist in experimentally infected animals (3, 4). However, the examination of only pools of mutants may result in a failure to distinguish between a mutation in a gene that is essential in vivo and a mutation in a gene that reduces the capacity of the mutant to compete with other mutants in vivo. In addition, it is not possible to fully assess the virulence of individual mutants within populations. Therefore, STM needs to be complemented with direct comparisons of isolated mutants for their capacity to infect, persist, and cause disease.